<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02747615</url>
  </required_header>
  <id_info>
    <org_study_id>586</org_study_id>
    <nct_id>NCT02747615</nct_id>
  </id_info>
  <brief_title>Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty</brief_title>
  <official_title>Efficacy of Preoperative Autologous Blood Donation and Tranexamic Acid in Revision Total Hip Arthroplasty: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <brief_summary>
    <textblock>
      Sixty patients aged between 60 and 75 years old of both sex of ASA physical status I and II&#xD;
      were included in this randomized study who were divided into the study group of 30 patients&#xD;
      who had been transfused autologous blood and the control group of 30 patients who had been&#xD;
      transfused only allogeneic blood. Parenteral iron preparation was given to all patients of&#xD;
      the study group after each donation. Intraoperatively all patients of the study group&#xD;
      received 2 grams of intravenous tranexamic acid. This study was conducted through the&#xD;
      laboratory analysis of the hemoglobin and the hematocrit values during blood donation and for&#xD;
      both groups in the pre-operative and the post-operative period and the assessment of the&#xD;
      amount of transfused blood units in both groups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 60 patients were included in this randomized study that were divided into a study&#xD;
      group of 30 patients, who had been transfused autologous blood and a control group of 30&#xD;
      patients who had been transfused only allogeneic blood. Parenteral iron preparation was given&#xD;
      to all patients of the study group after each donation. Intraoperatively all patients of the&#xD;
      study group received 2 g of intravenous TXA.&#xD;
&#xD;
      This study was conducted through laboratory analysis of hemoglobin and hematocrit values&#xD;
      during blood donation and for both groups in the preoperative and the postoperative period&#xD;
      and the assessment of the amount of transfused blood units in both groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">October 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Transfused Allogeneic Blood Units (in Digits).</measure>
    <time_frame>48-72 hours after surgery.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Our Secondary Outcome Measure Was to Assess the Post-operative Hospital Stay (Days).</measure>
    <time_frame>48-72 hours after surgery.</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Revision Total Hip Arthroplasty (RTHA)</condition>
  <arm_group>
    <arm_group_label>Control group (n=30)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The control group, which consisted of 30 patients who were transfused only allogeneic blood.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Preoperative blood donation (n=30)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>the study group including 30patients who were transfused pre-operatively donated autologous blood, either during surgery or after it.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>transfused pre-operatively donated autologous blood.</intervention_name>
    <description>Pre-operative autologous donation for minimising perioperative allogeneic blood transfusion</description>
    <arm_group_label>Preoperative blood donation (n=30)</arm_group_label>
    <other_name>Pre-operative autologous donation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intravenous tranexamic acid (TXA) infusion</intervention_name>
    <description>Intravenous tranexamic acid is a safe pharmacological treatment to reduce blood loss and transfusion requirements in patients undergoing major orthopedic surgery.</description>
    <arm_group_label>Preoperative blood donation (n=30)</arm_group_label>
    <other_name>KapronÂ®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>transfused only allogeneic blood.</intervention_name>
    <arm_group_label>Control group (n=30)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective revision total hip replacement surgery was performed in 60 patients aged&#xD;
             between 60 and 75 years old of both sex of ASA physical status I and II of 70-90 kg&#xD;
             body weight and height 160-180 cm.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  This study excluded cases of revision total hip arthroplasty (RTHA) for infection or&#xD;
             fractures as well as early revisions for dislocations secondary to implant&#xD;
             malposition. Preoperative autologous blood donation was not done in patients with&#xD;
             cardiac decompensation, severe hemodynamic problems, respiratory insufficiency, severe&#xD;
             defect of central nervous system, active infection, blood disease or coagulopathies.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>April 3, 2016</study_first_submitted>
  <study_first_submitted_qc>April 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2016</study_first_posted>
  <results_first_submitted>August 10, 2020</results_first_submitted>
  <results_first_submitted_qc>September 4, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 7, 2020</results_first_posted>
  <last_update_submitted>September 4, 2020</last_update_submitted>
  <last_update_submitted_qc>September 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Dr.Ibrahim Mamdouh Esmat</investigator_full_name>
    <investigator_title>MD, Lecturer of Anesthesia and Intensive Care Medicine, Ain Shams University Hospitals</investigator_title>
  </responsible_party>
  <keyword>Autologous blood donation, allogeneic blood transfusion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control Group (n=30)</title>
          <description>The control group, which consisted of 30 patients who were transfused only allogeneic blood.&#xD;
transfused only allogeneic blood.</description>
        </group>
        <group group_id="P2">
          <title>Preoperative Blood Donation (n=30)</title>
          <description>the study group including 30patients who were transfused pre-operatively donated autologous blood, either during surgery or after it.&#xD;
transfused pre-operatively donated autologous blood.&#xD;
intravenous tranexamic acid (TXA) infusion</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Group (n=30)</title>
          <description>The control group, which consisted of 30 patients who were transfused only allogeneic blood.&#xD;
transfused only allogeneic blood.</description>
        </group>
        <group group_id="B2">
          <title>Preoperative Blood Donation (n=30)</title>
          <description>the study group including 30patients who were transfused pre-operatively donated autologous blood, either during surgery or after it.&#xD;
transfused pre-operatively donated autologous blood.&#xD;
intravenous tranexamic acid (TXA) infusion</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="60"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.8" spread="4.4"/>
                    <measurement group_id="B2" value="67.4" spread="4.1"/>
                    <measurement group_id="B3" value="67.6" spread="4.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Egypt</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Transfused Allogeneic Blood Units (in Digits).</title>
        <time_frame>48-72 hours after surgery.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group (n=30)</title>
            <description>The control group, which consisted of 30 patients who were transfused only allogeneic blood.&#xD;
transfused only allogeneic blood.</description>
          </group>
          <group group_id="O2">
            <title>Preoperative Blood Donation (n=30)</title>
            <description>the study group including 30patients who were transfused pre-operatively donated autologous blood, either during surgery or after it.&#xD;
transfused pre-operatively donated autologous blood.&#xD;
intravenous tranexamic acid (TXA) infusion</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Transfused Allogeneic Blood Units (in Digits).</title>
          <units>units</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" lower_limit="1.0" upper_limit="3.0"/>
                    <measurement group_id="O2" value="0.0" lower_limit="0.0" upper_limit="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Our Secondary Outcome Measure Was to Assess the Post-operative Hospital Stay (Days).</title>
        <time_frame>48-72 hours after surgery.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group (n=30)</title>
            <description>The control group, which consisted of 30 patients who were transfused only allogeneic blood.&#xD;
transfused only allogeneic blood.</description>
          </group>
          <group group_id="O2">
            <title>Preoperative Blood Donation (n=30)</title>
            <description>the study group including 30patients who were transfused pre-operatively donated autologous blood, either during surgery or after it.&#xD;
transfused pre-operatively donated autologous blood.&#xD;
intravenous tranexamic acid (TXA) infusion</description>
          </group>
        </group_list>
        <measure>
          <title>Our Secondary Outcome Measure Was to Assess the Post-operative Hospital Stay (Days).</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.27" spread="1.11"/>
                    <measurement group_id="O2" value="3.20" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected over 24 hours postoperatively.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Control Group (n=30)</title>
          <description>The control group, which consisted of 30 patients who were transfused only allogeneic blood.&#xD;
transfused only allogeneic blood.</description>
        </group>
        <group group_id="E2">
          <title>Preoperative Blood Donation (n=30)</title>
          <description>the study group including 30patients who were transfused pre-operatively donated autologous blood, either during surgery or after it.&#xD;
transfused pre-operatively donated autologous blood.&#xD;
intravenous tranexamic acid (TXA) infusion</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Ibrahim Mamdouh Esmat</name_or_title>
      <organization>Ain-Shams University Hospitals</organization>
      <phone>01001241928</phone>
      <email>ibrahim_mamdouh@med.asu.edu.eg</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

